Eric P. Lefkofsky Sells 562,345 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 562,345 shares of Tempus AI stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $50.93, for a total transaction of $28,640,230.85. Following the sale, the chief executive officer now owns 9,457,283 shares in the company, valued at approximately $481,659,423.19. The trade was a 5.61 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Tempus AI Trading Up 0.5 %

TEM opened at $49.10 on Friday. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The business’s 50 day moving average is $54.02 and its two-hundred day moving average is $52.54. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $91.45.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of TEM. First Horizon Advisors Inc. acquired a new stake in Tempus AI in the third quarter valued at $30,000. Operose Advisors LLC purchased a new position in shares of Tempus AI in the 4th quarter worth about $25,000. Farther Finance Advisors LLC purchased a new position in shares of Tempus AI in the 4th quarter worth about $34,000. Prestige Wealth Management Group LLC raised its holdings in shares of Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after purchasing an additional 965 shares during the period. Finally, NewEdge Advisors LLC acquired a new stake in shares of Tempus AI in the fourth quarter valued at about $49,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Analyst Ratings Changes

TEM has been the subject of several recent analyst reports. TD Cowen reaffirmed a “buy” rating and set a $74.00 price objective (up from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Loop Capital decreased their price objective on Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a report on Tuesday, January 14th. William Blair reiterated a “market perform” rating on shares of Tempus AI in a report on Tuesday, February 25th. Guggenheim restated a “buy” rating on shares of Tempus AI in a report on Tuesday, February 25th. Finally, Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and upped their target price for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $61.18.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.